US October existing home sales 4.43m vs 4.38m expected

S&P 500 futures flat after 3-day rally; gold hits new highs. Inflation data & Fed speak loom.

AI predicts 1000+ diseases w/ 70% accuracy up to 20 yrs out. Risk jumps 19x for cancer w/ diabetes. High potential for insurers.

Kenvue (KVUE) shares dip 7.5% on Tylenol-autism link claims, then rebound 5%. Traders eye valuation amid unproven risks.

US tariffs hit $350B/yr, a shadow VAT on consumers, slowing debt growth but raising costs for families.

Nomura Asset Mgmt sees Japanese equities as attractively valued into 2026, citing governance reforms and relief from capped U.S. tariffs. It remains underweight autos and overweight IT.

Innovent's Xinermei surges 155% YTD, challenging rivals. Morningstar sees 3.5B yuan peak sales by 2029.

Dow, S&P, Nasdaq futures dip 0.1% after record highs. NVDA, ORCL, TSLA lead gains; KVUE rebounds. Powell speech, MU earnings, PCE data loom.